BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23641438)

  • 1. Psychotropics and sudden cardiac death.
    Gören JL; Dinh TA
    R I Med J (2013); 2013 Mar; 96(3):38-41. PubMed ID: 23641438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric medications and sudden cardiac death: putting the risk in perspective.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Feb; 53(2):23-5. PubMed ID: 25654571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
    Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT alterations in psychopharmacology: proven candidates and suspects.
    Alvarez PA; Pahissa J
    Curr Drug Saf; 2010 Jan; 5(1):97-104. PubMed ID: 20210726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for QT prolongation associated with acute psychotropic drug overdose.
    Miura N; Saito T; Taira T; Umebachi R; Inokuchi S
    Am J Emerg Med; 2015 Feb; 33(2):142-9. PubMed ID: 25445869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.
    Porta-Sánchez A; Gilbert C; Spears D; Amir E; Chan J; Nanthakumar K; Thavendiranathan P
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management.
    Fanoe S; Kristensen D; Fink-Jensen A; Jensen HK; Toft E; Nielsen J; Videbech P; Pehrson S; Bundgaard H
    Eur Heart J; 2014 May; 35(20):1306-15. PubMed ID: 24644307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Age and Sex on QT Prolongation in Patients Receiving Psychotropics.
    Rabkin SW
    Can J Psychiatry; 2015 May; 60(5):206-14. PubMed ID: 26174524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QTc interval diurnal variations in patients treated with psychotropic medications: implications for the evaluation of drug induced QTc changes.
    Cuomo A; Libri C; Barillà G; Cattolico M; Carmellini P; Fagiolini A
    Int Rev Psychiatry; 2022; 34(7-8):689-692. PubMed ID: 36786118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychotropic drugs and sudden death].
    Carreiro SV; Martins RR; De Carvalho A
    Acta Med Port; 2006; 19(2):151-64. PubMed ID: 17187717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced q-T prolongation.
    Kao LW; Furbee RB
    Med Clin North Am; 2005 Nov; 89(6):1125-44, x. PubMed ID: 16227057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic medications and sudden cardiac death.
    Harrison MO; Krishnan KR
    Psychopharmacol Bull; 2002; 36(3):91-9. PubMed ID: 12473967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic drugs, cardiac arrhythmia, and sudden death.
    Witchel HJ; Hancox JC; Nutt DJ
    J Clin Psychopharmacol; 2003 Feb; 23(1):58-77. PubMed ID: 12544377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychotropic drugs and QTc prolongation].
    De Wit LE; van Stiphout F; Groeneveld SA; Hassink RJ; Dekker D
    Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literature.
    Frassati D; Tabib A; Lachaux B; Giloux N; Daléry J; Vittori F; Charvet D; Barel C; Bui-Xuan B; Mégard R; Jenoudet LP; Descotes J; Vial T; Timour Q
    Can J Psychiatry; 2004 Feb; 49(2):100-5. PubMed ID: 15065743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of cardiovascular risks during treatment with psychotropic drugs.
    Glassman AH
    J Clin Psychiatry; 2002; 63 Suppl 9():12-7. PubMed ID: 12088171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.